JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 143,900 shares at a price of around 16.89 Hong Kong dollars per share.

18:58 02/04/2026

On March 30th, HSBC increased its holdings of Baiyunshan (00874) by 143,924 shares, with a price of 16.8915 Hong Kong dollars per share, for a total amount of approximately 2.4311 million Hong Kong dollars.

Hong Kong Stock Exchange latest data shows that on March 30, JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 143,924 shares, with a price of 16.8915 Hong Kong dollars per share, for a total amount of approximately 2.4311 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 19.9102 million shares, with a latest shareholding ratio of 9.05%.

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!